PG
ARNA

PEAK6 Group’s Arena Pharmaceuticals Inc ARNA Stock Holding History

PEAK6 Group’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$327K Buy
+7,500
New +$322K ﹤0.01% 2942

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

PEAK6 Group's ARNA Position: Q2 2018 in Review

PEAK6 Group opened a new position in Arena Pharmaceuticals Inc (ARNA) in Q2 2018: 1,794 shares worth $78K. The stake represents ﹤0.01% of the portfolio and ranks #3792 among its holdings.

165 funds tracked by Wall St. Rank hold ARNA as of Q2 2018.

  • PEAK6 Group held 1,794 shares of Arena Pharmaceuticals Inc worth $78K as of Q2 2018.
  • Arena Pharmaceuticals Inc was a new PEAK6 Group position in Q2 2018.
  • Arena Pharmaceuticals Inc made up ﹤0.01% of PEAK6 Group's portfolio in Q2 2018, its #3792 holding.
  • 165 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.